PeptideDB

Chamaejasmenin B

CAS No.: 89595-71-1

Chamaejasmenin B is a compound isolated from Stellera chamaejasme L. Chamaejasmenin B has anticancer and antitumor activ
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Chamaejasmenin B is a compound isolated from Stellera chamaejasme L. Chamaejasmenin B has anticancer and antitumor activity, inhibiting cancer cell migration and invasion, and inhibiting tumor metastasis.Chamaejasmenin B is used in the study of cancers such as breast cancer.
In vitro Chamaejasmenin B在8种人类实体瘤细胞系(HepG2, SMMC-7721, A549, MG63, U2OS, KHOS, HCT-116, HeLa)中显示出显著的抗增殖作用,IC50值介于1.08至10.8 μmol/L之间。在对这两种化合物最敏感的A549和KHOS细胞中,其抗增殖效应的机制被明确了,这两种化合物显著诱导DNA损伤标志物γ-H2AX的表达以及细胞凋亡。此外,用这两种化合物处理细胞还显著引起G(0)/G(1)期阻滞。
molecular weight 570.54
Molecular formula C32H26O10
CAS 89595-71-1
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Li Q, et al. Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment. Front Immunol. 2021;12:774230. 2. Li Q, et al. Chamaejasmenin B, a novel candidate, inhibits breast tumor metastasis by rebalancing TGF-beta paradox. Oncotarget. 2016;7(30):48180-4819 3. Zhang C, Et al. In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L. Acta Pharmacol Sin. 2013;34(2):262-270.